A Mass Balance Study of [14C]ABSK021
NCT06186583
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
Pimicotinib（ABSK021）
Sponsor
Abbisko Therapeutics Co, Ltd